Transamerica Financial Advisors’s Celgene Corp CELG Stock Holding History

Transamerica Financial Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,871	Closed	-$388K	–	787
2016 Q1	$388K	Sell	3,871 -698	-15%	-$71.9K	0.03%	240
2015 Q4	$548K	Buy	4,569 +2,857	+167%	+$331K	0.04%	222
2015 Q3	$186K	Sell	1,712 -112	-6%	-$13.9K	0.01%	286
2015 Q2	$212K	Sell	1,824 -17	-0.9%	-$1.94K	0.02%	324
2015 Q1	$213K	Sell	1,841 -2,752	-60%	-$329K	0.01%	321
2014 Q4	$514K	Buy	4,593 +2,575	+128%	+$272K	0.04%	181
2014 Q3	$192K	Sell	2,018 -1,990	-50%	-$180K	0.02%	258
2014 Q2	$345K	Buy	+4,008	New	+$305K	0.03%	221
2014 Q1	–	Sell	-5,068	Closed	-$429K	–	689
2013 Q4	$429K	Sell	5,068 -4,678	-48%	-$370K	0.05%	164
2013 Q3	$752K	Buy	9,746 +5,070	+108%	+$355K	0.1%	115
2013 Q2	$274K	Buy	+4,676	New	+$281K	0.04%	181

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Transamerica Financial Advisors's CELG Position: Q2 2016 in Review

Transamerica Financial Advisors sold out of Celgene Corp (CELG) in Q2 2016, closing a stake of 3,871 shares — an estimated $388K sold.

Transamerica Financial Advisors first reported a position in CELG in Q2 2013 and held it in 11 quarters. The position peaked at $752K in Q3 2013. 1,218 funds tracked by Wall St. Rank hold CELG as of Q2 2016.

Transamerica Financial Advisors reported no remaining Celgene Corp position as of Q2 2016 after selling out during the quarter.
Transamerica Financial Advisors sold 3,871 Celgene Corp shares in Q2 2016, an estimated $388K.
Transamerica Financial Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 11 quarters.
Transamerica Financial Advisors's Celgene Corp position peaked at $752K in Q3 2013.
1,218 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2016.

Based on Transamerica Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.